Clinical Trial Update: Can Short Latency Afferent Inhibition Give us Clues to Better DYT 1 Dystonia Treatments?

View source ↗

Summary

This clinical trial update discusses using short latency afferent inhibition as a potential approach to improve treatments for DYT1 dystonia. The University of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystonia
• Dyt1 Dystonia

Snippet

Sponsor: University of Florida | Conditions: DYT-1, DYT1 | Status: COMPLETED